DCLK2 and nonpapillary renal cell carcinoma: Recently an unexpected kinase, doublecortin like kinase 2 (DCLK2), was discovered to be a direct TBK1 activator in ccRCC through a kinome-wide siRNA screening (Hu et al., 2024).